TY - JOUR AU - Liu, W. AU - Xu, J. AU - Liu, Y. AU - Yu, X. AU - Tang, X. AU - Wang, Z. PY - 2014 DA - 2014// TI - Anthocyanins potentiate the activity of trastuzumab in human epidermal growth factor receptor 2-positive breast cancer cells in vitro and in vivo JO - Mol Med Rep VL - 10 ID - Liu2014 ER - TY - JOUR AU - Rakha, E. A. AU - Pinder, S. E. AU - Bartlett, J. M. AU - Ibrahim, M. AU - Starczynski, J. AU - Carder, P. J. PY - 2015 DA - 2015// TI - Updated UK Recommendations for HER2 assessment in breast cancer JO - J Clin Pathol VL - 68 UR - https://doi.org/10.1136/jclinpath-2014-202571 DO - 10.1136/jclinpath-2014-202571 ID - Rakha2015 ER - TY - JOUR AU - Gianni, L. AU - Dafni, U. AU - Gelber, R. D. AU - Azambuja, E. AU - Muehlbauer, S. AU - Goldhirsch, A. PY - 2011 DA - 2011// TI - Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial JO - Lancet Oncol VL - 12 UR - https://doi.org/10.1016/S1470-2045(11)70033-X DO - 10.1016/S1470-2045(11)70033-X ID - Gianni2011 ER - TY - JOUR AU - Gianni, L. AU - Eiermann, W. AU - Semiglazov, V. AU - Manikhas, A. AU - Lluch, A. AU - Tjulandin, S. PY - 2010 DA - 2010// TI - Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort JO - Lancet VL - 375 UR - https://doi.org/10.1016/S0140-6736(09)61964-4 DO - 10.1016/S0140-6736(09)61964-4 ID - Gianni2010 ER - TY - JOUR AU - Baselga, J. AU - Bradbury, I. AU - Eidtmann, H. AU - Cosimo, S. AU - Azambuja, E. AU - Aura, C. PY - 2012 DA - 2012// TI - Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial JO - Lancet VL - 379 UR - https://doi.org/10.1016/S0140-6736(11)61847-3 DO - 10.1016/S0140-6736(11)61847-3 ID - Baselga2012 ER - TY - JOUR AU - Hanna, W. M. AU - Ruschoff, J. AU - Bilous, M. AU - Coudry, R. A. AU - Dowsett, M. AU - Osamura, R. Y. PY - 2014 DA - 2014// TI - HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity JO - Mod Pathol VL - 27 UR - https://doi.org/10.1038/modpathol.2013.103 DO - 10.1038/modpathol.2013.103 ID - Hanna2014 ER - TY - JOUR AU - Jimenez, R. E. AU - Wallis, T. AU - Tabasczka, P. AU - Visscher, D. W. PY - 2000 DA - 2000// TI - Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization JO - Mod Pathol VL - 13 UR - https://doi.org/10.1038/modpathol.3880007 DO - 10.1038/modpathol.3880007 ID - Jimenez2000 ER - TY - JOUR AU - Perez, E. A. AU - Suman, V. J. AU - Davidson, N. E. AU - Martino, S. AU - Kaufman, P. A. AU - Lingle, W. L. PY - 2006 DA - 2006// TI - HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.03.4744 DO - 10.1200/JCO.2005.03.4744 ID - Perez2006 ER - TY - JOUR AU - Wolff, A. C. AU - Hammond, M. E. AU - Schwartz, J. N. AU - Hagerty, K. L. AU - Allred, D. C. AU - Cote, R. J. PY - 2007 DA - 2007// TI - American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer JO - Arch Pathol Lab Med VL - 131 ID - Wolff2007 ER - TY - JOUR AU - Wolff, A. C. AU - Hammond, M. E. AU - Hicks, D. G. AU - Dowsett, M. AU - McShane, L. M. AU - Allison, K. H. PY - 2013 DA - 2013// TI - Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2013.50.9984 DO - 10.1200/JCO.2013.50.9984 ID - Wolff2013 ER - TY - JOUR AU - Xiao, Y. AU - Gao, X. AU - Maragh, S. AU - Telford, W. G. AU - Tona, A. PY - 2009 DA - 2009// TI - Cell lines as candidate reference materials for quality control of ERBB2 amplification and expression assays in breast cancer JO - Clin Chem VL - 55 UR - https://doi.org/10.1373/clinchem.2008.120576 DO - 10.1373/clinchem.2008.120576 ID - Xiao2009 ER - TY - JOUR AU - Hammond, M. E. AU - Barker, P. AU - Taube, S. AU - Gutman, S. PY - 2003 DA - 2003// TI - Standard reference material for Her2 testing: report of a National Institute of Standards and Technology-sponsored Consensus Workshop JO - Appl Immunohistochem Mol Morphol VL - 11 UR - https://doi.org/10.1097/00129039-200306000-00001 DO - 10.1097/00129039-200306000-00001 ID - Hammond2003 ER - TY - JOUR AU - Bartlett, J. M. AU - Ibrahim, M. AU - Jasani, B. AU - Morgan, J. M. AU - Ellis, I. AU - Kay, E. PY - 2007 DA - 2007// TI - External quality assurance of HER2 fluorescence in situ hybridisation testing: results of a UK NEQAS pilot scheme JO - J Clin Pathol VL - 60 UR - https://doi.org/10.1136/jcp.2006.040840 DO - 10.1136/jcp.2006.040840 ID - Bartlett2007 ER - TY - JOUR AU - Zhang, R. AU - Han, Y. AU - Huang, J. AU - Ma, L. AU - Li, Y. AU - Li, J. PY - 2014 DA - 2014// TI - Results of first proficiency test for KRAS testing with formalin-fixed, paraffin-embedded cell lines in China JO - Clin Chem Lab Med VL - 52 UR - https://doi.org/10.1515/cclm-2014-0227 DO - 10.1515/cclm-2014-0227 ID - Zhang2014 ER - TY - JOUR AU - Hung, T. AU - Wolber, R. AU - Garratt, J. AU - Kalloger, S. AU - Gilks, C. B. PY - 2010 DA - 2010// TI - Improved breast cancer biomarker detection through a simple, high frequency, low cost external proficiency testing program JO - Pathology VL - 42 UR - https://doi.org/10.3109/00313025.2010.520306 DO - 10.3109/00313025.2010.520306 ID - Hung2010 ER - TY - JOUR AU - Martin, V. AU - Camponovo, A. AU - Ghisletta, M. AU - Bongiovanni, M. AU - Mazzucchelli, L. PY - 2012 DA - 2012// TI - Internal quality assurance program for ERBB2 (HER2) testing improves the selection of breast cancer patients for treatment with trastuzumab JO - Pathol Res Int VL - 2012 UR - https://doi.org/10.1155/2012/261857 DO - 10.1155/2012/261857 ID - Martin2012 ER - TY - JOUR AU - Vyberg, M. AU - Nielsen, S. AU - Roge, R. AU - Sheppard, B. AU - Ranger-Moore, J. AU - Walk, E. PY - 2015 DA - 2015// TI - Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests JO - BMC Health Serv Res VL - 15 UR - https://doi.org/10.1186/s12913-015-1018-6 DO - 10.1186/s12913-015-1018-6 ID - Vyberg2015 ER - TY - JOUR AU - Rhodes, A. AU - Jasani, B. AU - Couturier, J. AU - McKinley, M. J. AU - Morgan, J. M. AU - Dodson, A. R. PY - 2002 DA - 2002// TI - A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer JO - Am J Clin Pathol VL - 117 UR - https://doi.org/10.1309/4NCM-QJ9W-QM0J-6QJE DO - 10.1309/4NCM-QJ9W-QM0J-6QJE ID - Rhodes2002 ER - TY - JOUR AU - Vanden Bempt, I. AU - Loo, P. AU - Drijkoningen, M. AU - Neven, P. AU - Smeets, A. AU - Christiaens, M. R. PY - 2008 DA - 2008// TI - Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.13.4296 DO - 10.1200/JCO.2007.13.4296 ID - Vanden Bempt2008 ER - TY - JOUR AU - Wester, K. AU - Andersson, A. C. AU - Ranefall, P. AU - Bengtsson, E. AU - Malmstrom, P. U. AU - Busch, C. PY - 2000 DA - 2000// TI - Cultured human fibroblasts in agarose gel as a multi-functional control for immunohistochemistry. Standardization Of Ki67 (MIB1) assessment in routinely processed urinary bladder carcinoma tissue JO - J Pathol VL - 190 UR - https://doi.org/3.0.CO;2-E DO - 3.0.CO;2-E ID - Wester2000 ER - TY - JOUR AU - Hasan, T. AU - Carter, B. AU - Denic, N. AU - Gai, L. AU - Power, J. AU - Voisey, K. PY - 2015 DA - 2015// TI - Evaluation of cell-line-derived xenograft tumours as controls for immunohistochemical testing for ER and PR JO - J Clin Pathol VL - 68 UR - https://doi.org/10.1136/jclinpath-2015-203066 DO - 10.1136/jclinpath-2015-203066 ID - Hasan2015 ER - TY - JOUR AU - Taetle, R. AU - Jones, O. W. AU - Honeysett, J. M. AU - Abramson, I. AU - Bradshaw, C. AU - Reid, S. PY - 1987 DA - 1987// TI - Use of nude mouse xenografts as preclinical screens. Characterization of xenograft-derived melanoma cell lines JO - Cancer VL - 60 UR - https://doi.org/3.0.CO;2-O DO - 3.0.CO;2-O ID - Taetle1987 ER - TY - JOUR AU - Holliday, D. L. AU - Speirs, V. PY - 2011 DA - 2011// TI - Choosing the right cell line for breast cancer research JO - Breast Cancer Res VL - 13 UR - https://doi.org/10.1186/bcr2889 DO - 10.1186/bcr2889 ID - Holliday2011 ER - TY - JOUR AU - Czerski, L. AU - Majors, A. AU - Ng, T. C. AU - Vijayakumar, S. AU - Weichselbaum, R. PY - 1993 DA - 1993// TI - Growth and magnetic resonance characteristics of human squamous cell carcinoma xenografts implanted with cells suspended in Matrigel JO - NMR Biomed VL - 6 UR - https://doi.org/10.1002/nbm.1940060503 DO - 10.1002/nbm.1940060503 ID - Czerski1993 ER -